Article
Analysis of CCND3 mutations in diffuse large B-cell lymphoma
2024-02-08
Abstract excerpt
<title>Abstract</title> <p>Diffuse large B-cell lymphoma (DLBCL), accounts for 30–40% of newly diagnosed lymphomas, has an overall cure rate of approximately 60%. Despite previous reports suggesting a negative prognostic association between CCND3 mutations and Burkitt lymphoma, their prognostic implications in DLBCL remain controversial. To investigate this, we evaluated CCND3 mutation status in 2059 DLBCL patien...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 6f136dff-f2d1-58c4-99e3-93161f9d2f4e
- DOI
- 10.21203/rs.3.rs-3884990/v1
